A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. The metric has seen a significant loss of -12.21% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -38.88%. Over the past 30 days, the price of EYPT has fallen by 4.81%. And in the last five days, it has surged by 17.84%.
EyePoint Pharmaceuticals Inc’s stock has seen a rocky market performance. The company’s stock achieved a 1-year high of $21.25 on 05/03/24, and the lowest price during that time was $3.91, recorded on 04/09/25.
52-week price history of EYPT Stock
The history of a stock’s 52-week high and low prices can provide important information about its current state and future potential. EyePoint Pharmaceuticals Inc’s current trading price is -69.23% away from its 52-week high, while its distance from the 52-week low is 67.26%. The stock’s price range for this period has been between $3.91 and $21.25. The Healthcare sector company’s shares saw a trading volume of about 0.53 million for the day, which was lower than the average daily volume of 0.85 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
EyePoint Pharmaceuticals Inc (EYPT) has experienced a quarterly decline of -25.85% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 449.49M and boasts a workforce of 165 employees.
How Moving Averages and Trading Volume Data Work Together
Based on Barchart.com data, the company’s moving average over the 100-day period was 6.94, with a change in price of -2.46. Similarly, EyePoint Pharmaceuticals Inc recorded 849,768 in trading volume during the last 100 days, posting a change of -27.33%.
EYPT’s Debt-to-Equity Ratio: A Comprehensive Review
A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for EYPT stands at 0.07. Similarly, the long-term debt-to-equity ratio is also 0.06.
EYPT Stock Stochastic Average
As of today, the raw stochastic average of EyePoint Pharmaceuticals Inc over the past 50 days is 71.08%. This is a decrease compared to the raw stochastic average of the last 20 days, which was recorded at 85.11%. Additionally, the Stochastic %K and %D values for the company were 91.91% and 85.93%, respectively, over the past 20 days.
